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In a previous publication (1) the fact was established that rabbits, 
immunized with degraded, avirulent, non-type-specific pneumococci 
Mso called R strains derived from any one of the three types--acquire 
a considerable degree of resistance against subsequent infection with 
virulent Type III pneumococci.  Active resistance was demonstrable 
under these conditions in spite of the fact that the sera of the ~mmun- 
ized rabbits contained no type-specific antibodies capable of aggluti- 
nating Type III S cells, or of precipitating the soluble specific substance 
derived from Type III cultures, or of conferring passive protection on 
mice against Type III infection.  It was suggested (1) that this form 
of active immunity, effective in the absence of demonstrable type- 
specific antibodies and unrelated to the variety of pneumococcus used 
for immunization, differed in principle from type-specific immunity. 
The previous experiments were restricted to the study of the active 
resistance to Pneumococcus Type III.  However, it seemed possible 
that this form of immunity--induced by immunization with R cells-- 
might be effective against infection with other virulent types of pneu- 
mococcus.  Consequently, additional studies have been carried on to 
determine whether the apparently non-type-specificresistancethusin- 
duced is as effective against Type I and Type II as against Type III. 
The results are recorded in this communication.  In view of the dif- 
ferences which appear to exist between the form of active immunity 
stimulated in rabbits by type-specific S organisms and intimately as- 
sociated with type-specific antibodies, and active resistance induced 
by prolonged immunization with R  cells, further investigation into 
the nature and mechanism of the latter type of immunity is in progress. 
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In addition, the work has been extended to include passive immunity 
in order to determine whether the blood of rabbits immunized with R 
pneumococci, is capable of conferring protection upon normal animals 
of the  same or of different  species.  The  results  of experiments  on 
passive immunity are also included in this report. 
Methods. 
Antigens.--An  R  strain originally  derived from Type II S culture (designated 
R~), an R strain similarly derived from Type I  S culture (designated  R0, and a 
Type III S strain were employed for the immunization  of all rabbits used in the 
experiments  on active immunity.  Only the R2 strain was used for immunization 
in the tests for passive immunity. 
Vaccines were prepared from 12 to 14 hour plain broth cultures.  The organ- 
isms, removed from the broth by centrifugation,  were resuspended in physiological 
salt  solution  in such  proportion that 0.5  cc. of the suspension  was equivalent 
in bacterial content to 1 cc. of original culture, and heat-killed at 56  ° for 30 minutes. 
Technique of Immunization.--The method of immunization,  described by Cole 
and Moore (2),  consisted  of a  total of 18 intravenous injections;  0.5  cc. doses 
of vaccine were given daily for 6 days followed by a week of rest until the proce- 
dure was repeated 3 times.  As a rule, the animals were tested 9 to 14 days after 
the last dose. 
Protection Tests.--12 to 14 hour blood broth cultures of virulent pneumococci of 
Types I, II, and III were used in all tests for active and passive immunity.  Type 
I cultures possessed  a maximum virulence  for rabbits  of 0.000001 cc.; Type II 
were usually fatal in 0.000001 cc. and always in 0.00001 cc. amounts; Type III 
killed regularly at 0.0001 cc.  In most of the experiments,  in order to follow the 
degree of the baeteremia,  blood cultures  were taken at frequent intervals  during 
the course of infection as previously described (3). 
Rabbits tested for increased resistance  to Type I infection had previously been 
treated  as  follows:  1 had been immunized  with R  pneumococci  derived from 
Type I S strain, 15 with R pneumococci derived from Type II S strain, and 3 with 
Type III S pneumococci.  Their sera were tested for the presence of agglutinins 
for R organisms and for the S forms of the three specific types.  In no instance 
were type-specific agglutinins  demonstrable;  there were, however, agglutinins for 
R  cells present in titres of 1:640 to 1:1280.  Antibody response was similar  re- 
gardless  of organisms  used for immunization.  That rabbit  avirulent strains  of 
Type III stimulate in rabbits antibody formation of the same character as that 
elicited by R ceils has been previously described (4).  The infecting dose of Type I 
pneumococcus,  in  every instance,  represented  10,000 to  100,000 lethal  doses. 
By keeping  the  test  strain  at a  maximum virulence  for rabbits of 0.000001 co., 
0.01 cc., or 0.1 ec. of such culture  constituted the dosage of organisms employed. WILLIAM  S.  TILLETT  793 
In each experiment, in addition to the immunized rabbits, normal animals receiv- 
ing the minimal lethal dose and others the  test dose served as controls of the 
virulence of the culture. 
TABLE  L 
Adive Immunity against Infection witk Pneumococcus Type I in Rabbits Immunized 
witk R Strains.  (Tkree Rabbitsimmunlzed witk Sm Are Also Included.) 
Number of  Immunized  Infected with  Number 
Pneumococcus  Route of infection  Number died  rabbits  with  Type IH  survived 
Total 22. 
R1 
Sm 
R2 
R2 
Normal 
controls 
0.01 
0.1 
0.01 
0.1 
0.01 
0.1 
0.01 
0.1 
0.01 
0.000001 
0.000001 
0.000001 
Intravenous 
Intraperitoneal 
Intradermal 
Intravenous 
Intmperitoneal 
Intradermal 
0 
1" 
0 
It 
0 
0 
0 
0 
19 
Total  9  0 
* Animal died 8 days after infection. 
'f Animal died 5 days after infection. 
Animal died 7 days after infection. 
died within 36 hours. 
Controls receiving test dose of culture 
Active Immunity. 
Rabbits  were  tested  for  resistance  to  infection by  the injection 
of  organisms  intravenously,  intraperitoneaUy,  and  intradermaUy 
(Table I).  Blood cultures were taken at frequent intervals in order 
to observe the duration and degree of the bacteremia. 794  IMMUNITY  TO PNEU~OCOCCUS  INFECTION 
Rabbits Infected Intravenously.---Of 12 rabbits infected intravenously, 5 of which 
received 0.01 co., and 7 0.1 ec. each of virulent Type I  culture, 10 survived.  The 2 
which finally succumbed, lived 5 and 8 days respectively, whereas normal rabbits 
receiving the same dose died in 24 to 48 hours.  As evidence of the duration of the 
immunity, 2 of the rabbits in this group were tested 4½ months after the last im- 
munizing dose and found to be resistant.  As demonstrated  by blood cultures, 
organisms persisted in the circulation for 3 to 6 days,  increasing and decreasing 
in  number  irregularly  until  their  final  disappearance.  Even  in the  two  fatal 
instances, the animals possessed some degree of partial immunity as revealed by 
the fact that both lived several days longer than the controls, that neither suffered 
an  overwhelming septicemia,  and that  at autopsy each  showed evidence of at- 
tempted  localization  in  the  form  of pleurisy  and  pericarditis.  A  bacteremia 
characterized by an irregular course was previously shown to occur when R  im- 
munized rabbits  were infected with a  rabbit  virulent  strain  of Type III pneu- 
mococcus (1).  This form of bacteremia appears to be characteristic of the benign 
blood  infection  occurring when  rabbits,  immunized  with  R  cells,  are  infected 
intravenously  with  any of the  specific  types of  pneumococcus and  suggests  a 
similarity in the mechanism of recovery in each instance. 
Rabbits Infected Intraperitoneally.--Four  rabbits, immunized with R~ organisms, 
were infected intraperitoneally;  1 received 0.1 cc. and 3 received 0.01 co. of Type I 
pneumococci.  The latter  3 auinmls survived; the one injected with 0.1 cc. lived 
7 days.  In the 3  animals  which survived,  only a  few bacteria were transiently 
present in the blood stream.  The duration of cocci in the peritoneal cavity was 
not determined. 
Rabbits Infected Intradermally.--Type I  organisms in doses of 0.01  cc. and 0.1 
cc. were introduced  intradermally into 6 rabbits which had previously been im- 
munized  with  R~  cells.  All  6  animals  survived.  The  local  lesion  developed 
rapidly; in 24 to 48 hours it appeared  fulminating, ustmlly reddish purple, edema- 
tous, spreading ventrally in a well defined and elevated baud and forming a boggy 
pouch of edema over the more dependent portions of the abdominal wall.  Areas 
of ecchymosis were commonly present.  Normal rabbits  reacted with a  similar 
lesion,  although  succumbing  to  the  infection.  Furthermore,  blood  cultures 
revealed a striking difference in the course of the infection in normal and immun- 
ized animals.  The blood stream of immune rabbits either remained sterile or con- 
tained only a few organisms transiently present.  In sharp contrast, normal rab- 
bits developed, within a  few hours, a  blood infection which increased rapidly in 
severity until death ensued from an overwhelming septicemia.  Recently Goodner 
~5) has reported results obtained following intradermal injection of Type I pneu- 
mococci.  The lesion which he describes as occurring in normal rabbits is identical 
with the inflammatory reaction encountered in the animals used in these experi- 
ments.  Results which have been obtained following the intradermal inoculation 
of pneumococci into normal, type-specifically immune, and R  immunized rabbits 
will be reported later in a separate communication. WILLIA~  S.  TILLETT  795 
In addition to the rabbits immunized with R organisms and tested for resistance 
to infection with Type I, 3 rabbits which had received similar preliminary injec- 
tions  were infected  intravenously  with  virulent  Type II  pneumococci.  They 
survived 10,000 lethal doses.  The character of the blood infection and the process 
of recovery were similar in all respects to those already observed in the case of 
infection with  Types I and III. 
From  the results of these experiments  with Type I  and  Type II 
pneumococci, and from those reported  (1) using Type III, it may be 
concluded that adequate immunization of rabbits with R pneumococci 
stimulates  the  development  of active  immunity  which  is  effective 
against any of the fixed types.  A  consideration of these results and 
their possible significance will be presented in the discussion. 
Passive Immunity. 
In the course of an analysis of the immunity induced  by repeated 
injections  of R  pneumococci, experiments  have been  carried  out to 
determine  whether  this  form of resistance  is passively transferable. 
Whole citrated blood and  serum of rabbits which have acquired re- 
sistance through immunization with R cells have been passively trans- 
ferred  to  normal  rabbits  and  also  to mice.  The  R  strain  used for 
immunization  was  derived  from Type II S  culture.  The  infecting 
organisms were  virulent  S strains  of  Type  I  or  Type  III.  These 
precautions were taken in order to minimize  the possible  part io'pa- 
tlon of type-specific antibodies.  The blood for transfusion was drawn 
9 to 14 days after the last immunizing dose. 
In the first experiments the procedure was to transfer whole blood 
or its constituents from resistant to normal rabbits and 24 hours later 
to  inject  the  recipients  with  virulent  pneumococci.  An example of 
the  results  obtained  following the passive transference  of whole ci- 
trated blood, plasma, cells, and serum is given in Table II. 
A description of this experiment will serve as an illustration of the 
method employed and the results obtained. 
From the ear vein of an R immunized rabbit 20 cc. of blood was allowed to drop 
into a tube containing 0.5 cc. of a saturated solution of sodium citrate.  This made 
in final dilution approximately a 2 per cent sodium citrate solution,  Immediately 
upon obtaining the desired amount, the blood was injected by means of a syringe 
into  the  ear vein of a normal  rabbit.  In making transfusions  from rabbit to 796  IMIM'UNITY TO  PNE~OCOCCUS  INFECTION 
rabbit no precaution was taken with regard to blood grouping.  Sometimes im- 
mediately after the operation the recipient would show evidence of shock, char- 
acterized by clonic and tonic muscular spasms.  Complete recovery usually oc- 
curred in 3 to 4 minutes.  In one instance death ensued and in 2 other animals 
permanent paralysis of the hind limbs resulted.  20 cc. of blood similarly collected 
in citrate were  separated  by centrifugation into plasma and cells.  An equal 
amount without citrate was  allowed to  clot  and the  serum collected.  Sterile 
TABLE  II. 
Passive Protection of Rabbits  against Pneumococcus Infection  by Transfusion  of 
Blood, Plasma, Cells, and Serum of Rabbits Immunized  with R Pneur~ococd. 
1.  Protocol of Course of Bacteremia in Anli-R Donor and Recipients. 
Time of 
blood culture 
2 hrs. 
6 hrs. 
10 hrs. 
20 hrs. 
24 hrs. 
30 hrs. 
48 hrs. 
72  hrs. 
96 hrs. 
5 days 
6  days 
9 days 
11 days 
Anti-R 
donor 
1 
13 
1 
58 
142 
32 
1 
0 
4 
0 
0 
0 
0 s 
Number of  colonies  per unit  of  blood 
Anfi-R reclpients 
Whole 
blood  Plasma  Serum 
42  86 
5  0 
9  15 
15  7 
1  2 
0  29  1 
1  1 
1  1 
0  12 
0  1 
0  8 
0  0 
0~  0  • 
Normal 
donor 
Cells 
113 
13 
142 
518  D 
oo 
D 
I  Normal recipients  Control 
0.0001 ee 
Type llI 
Whole  Serum 
blood 
20  1000 
2  816 
23  o0 
148 
272  D 
522 
D  D 
0.1 cc. of rabbit virulent  strain of Type III used as infecting  dose. 
D indicates death of the animal. 
S indicates survival  of the animal. 
Numerals represent number of colonies per unit of blood. 
precautions were  observed throughout the procedure.  20  cc.  of  whole blood, 
or its equivalent in plasma, cells, or serum were then injected intravenously  into 
normal rabbits.  24 hours later these rabbits were infected intravenously  with 
0.1 cc. of a rabbit virulent strain of Type III.  Normal rabbits which had received 
comparable amounts of whole blood or serum from other normals were similarly 
infected.  Other normal rabbits without preliminary  treatment were infected with 
the maximal test dose and the minimal  lethal amount of culture. WILLIAM  S.  TILLETT  797 
From Table II it may be seen that whole blood, plasma, and serum 
from resistant rabbits afforded protection against 1000 lethal doses of 
Type III pneumococcus, whereas blood cells alone were inadequate. 
Controls receiving normal blood or serum were unprotected.  Tabu- 
lation of the number of organisms in the blood cultures reveals the 
fact  that  the  resistant  rabbits  continued to  have pneumococci in 
varying numbers in the blood stream from 3 to 6 days before perma- 
nent sterility was attained.  Rabbits receiving normal blood, on the 
other hand, although possessing a slight initial capacity to reduce the 
number of circulating bacteria were unable to cope with the subse- 
quent rapid increase, and died of an overwhelming septicemia. 
Repetitions of protection experiments of this character using vim- 
lent Type I pneumococci instead of Type III gave results equally deft- 
nite, indicating that, as in the case of active immunity, passive pro- 
tection of rabbits is not limited as to type of infecting pneumococcus. 
From these experiments it is established that resistance induced in 
rabbits by immunization with R pneumococci can be passively trans- 
ferred to normal rabbits.  In titering the amount of blood necessary 
to confer passive protection it was found that 15 to 20 cc. were neces- 
sary against doses of culture as high as those constantly employed, i.e. 
1000 lethal doses of Type III or 10,000 to 100,000 of Type I.  This 
quantity of blood was regularly used in all subsequent experiments. 
In Table III the total number of transfusions and the results are re- 
corded.  It may be seen that, with the amount of blood transfused 
and the dosage of culture kept constant, the time elapsing between 
transfusion and injection of organisms has been varied from 1 hour to 
21 days.  Of 5 rabbits infected within 5 hours of the time of trans- 
fusion 4 died and 1 survived.  Twenty-three animals were infected 1 
to  7 days after  transfusion and of these 18  recovered.  One rabbit 
infected 14 days after transfusion, survived, and of 5 in which an in- 
terval of 3 weeks elapsed, 3 recovered. 
With the use of 8 to 10 cc. of serum, an amount comparable to that 
contained in 15 to 20 cc. of whole blood, protection was demonstrable 
but the results were somewhat less striking.  In Table III the results 
of protection tests by the use of serum are presented.  Of 5 rabbits 
infected 1 to 5 hours after serum administration, 4 survived.  With an 
interval of I  to 7 days, out of 9 animals tested, 4 survived; in 3 in- 798  IMMUNITY  TO  PNEIY~OCOCCUS  INFECTION 
TABLe. III. 
Passive  Protection  of  Rabbits  against  Pneumococcus  Infection  by  Transfusion  o/ 
Blood and Serum  of Rabbits Immunized  witk R  Pne~mococci. 
2.  Summary  of Results  of Passive Protection  Tests  in Rabbits. 
Rabbit No.  Amount of  blood  Time interval  Infection with  Result 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
6. 
20 
20 
16 
15 
15 
20 
15 
20 
20 
20 
20 
20 
20 
20 
20 
20 
15 
1hr. 
2  hrs. 
4  ~c 
0.1  cc. Type I 
0.1  "  "  " 
0.5  "  "  III 
4  ~ 
5  " 
24  " 
24  " 
24  " 
24  " 
24  " 
3  days 
3  " 
3  " 
3  " 
3  " 
4  " 
0.5  "  "  " 
O. 1  '"  "  I 
0. I  "  "  " 
0.5  "  "  III 
0.2  "  "  " 
0.2  "  "  " 
0.1  "  "  I 
O. 1  "  "  " 
0.01  "  "  " 
0.01  "  "  " 
0.5  "  "  III 
0.1  "  "  I 
D  6  days 
S 
D  4  days 
¢¢  4  ¢¢ 
g~  4  cc 
S 
L~ 
~c 
~C 
D  4  days 
S 
cc 
D  4  days 
15 
15 
20 
20 
20 
20 
17 
15 
15 
15 
20 
20 
20 
20 
20 
15 
20 
4  cc 
7  " 
7  " 
7  " 
7  " 
7  " 
7  " 
7  " 
7  " 
7  " 
14  " 
21  " 
21  " 
21  " 
21  " 
21  " 
0.01  "  "  " 
0.01  "  "  " 
0.01  "  "  " 
0.1  "  "  " 
0.1  "  "  " 
0.1  "  "  " 
0.4  "  "  III 
0.5  "  "  " 
O. 5  "  .... 
0.1  "  "  " 
0.01  "  "  I 
0.01  "  "  " 
0.01  "  "  " 
0.01  "  "  " 
0.01  "  "  " 
0.01  "  "  " 
S 
cl 
¢¢ 
D  4  days 
S 
~c 
D  8  days 
S 
cc 
c~ 
lc 
gc 
L~ 
D  indicates death  of the animal. 
S  indicates  survival  of the animal. WILLIAM  S.  TILLETT 
TABLE  III--Conduded. 
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Rabbit No.  Amount of  Time interval  Infection with  Result  sel'Unl 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
10 
10 
10 
10 
1 hr. 
2  hrs. 
4  u 
0.1  cc. Type I 
0.1  "  "  " 
O. 1  "  "  " 
0.5  "  "  III 
S 
~c 
CC 
D  7 days 
10  4 
10  24 
10  24 
8  24 
10  24 
12  3 
8  7 
8  7 
10  7 
10  7 
10  14 
10  21 
10  21 
days 
¢c 
g¢ 
O. 1  "  " 
0.5  "  " 
0.5  "  " 
O. 1  "  " 
O. 1  "  " 
0.4  "  " 
0.5  "  " 
0.01  "  " 
0.01  "  " 
O. 1  "  " 
O. 1  "  " 
O. 1  "  " 
,,  S 
I  D  10 days 
III  "  3  " 
I  S 
III  " 
"  D  7 days 
I  "  2  " 
"  S 
"  D  4  days 
"  "  2  " 
stances where the time interval was longer than 7 days, none of the 
animals recovered. 
In all of the experiments controls were used consisting of  rabbits 
which received quantities of normal whole bood or serum equal to the 
amount of immune blood or serum transferred.  Altogether 20 con- 
trol rabbits were transfused with normal whole blood and 10 recei.ved 
injections of normal serum.  They all  died of pneumococcus septi- 
cemia. 
Differences in the effectiveness of passive protection depending on 
the time elapsing between administration of serum or blood and the in- 
jection of the infecting organism may be noted in Table III.  In those 
instances where serum was employed, protection appeared to be most 
effective, if only a few hours elapsed before the injection of organisms. 
On the other hand, when whole blood was transfused, protection was 
less striking when the interval was short than when the animals were 
permitted to rest 24 hours or longer before infection.  The duration 
of the protection conferred by whole blood is evidenced by animals 
which  survived pneumococcus infection 3  weeks after  transfusion. 800  IM~XUNITY  TO PIVEIY~OCOCCIYS  INFECTION 
No definite conclusions can be drawn at the present  time  from  the 
results concerning the time intervals employed in passive protection 
tests.  The significant fact is that the circulating blood of rabbits im- 
munized with R pneumococci possesses active prinicples which, when 
transferred to normal rabbits,  confer upon the recipients protection 
against infection with virulent pneumococci. 
TABLE  IV* 
Comparison of Passive  Protection of Mice and Rabbits  by Serum of Rabbits Im- 
munized with R2 Pneumococci. 
Anti-R rabbit serum 
10 
10 
10 
10 
0.5 
0.5 
0.5 
0.5 
0.5 
None 
None 
None 
> 
Amount of culture 
Type I 
0.1 
0.01 
0.01 
0.01 
Results 
Rabbits  Mice 
D  24 hrs. 
S 
S 
S 
0.00001 
0.00001 
0.000001 
0.000001 
0.000001 
Controls 
0.000001 
0.000001 
0.000001 
D  60 hrs. 
D  24 hrs. 
D  24 hrs. 
D  36 hrs. 
D  36 hrs. 
D  40 hrs. 
D  24 hrs. 
D  24 hrs. 
D  30 hrs. 
D indicates death and figures the number of hours before death of animal. 
* 2 hours following intraperitoneal injection of serum all animals were infected 
intraperitoneally with virulent culture in amounts indicated. 
In contrast  to  the effective protection of  rabbits  just  described, 
attempts to protect mice by the use of the same sera have been entirely 
negative.  From Table IV it may be seen that serum which protected 
rabbits against 0.01 cc. did not protect mice against even 0.000001 cc. 
of culture.  This was true in spite of the fact that the mice received a 
much larger amount of serum per unit of body weight than  did the 
rabbits.  Repeated attempts to protect mice with resistant rabbit's 
serum have failed regardless of whether the infecting organisms were WILLIAM S. TILLETT  801 
introduced simultaneously with serum or after intervals of 2, 6,12, or 
24  hours.  The whole citrated blood of rabbits  has been similarly 
tested and found to be without effect in mice. 
It may be concluded, then, that the serum or whole blood of rabbits 
immunized by repeated injections of R pneumococci, although able to 
afford protection to normal animals of the same species, is incapable, 
under comparable conditions, of conferring protection upon animals of 
a foreign species--i.e, mice.  These results are in striking contrast to 
those obtained with antipneumococcus sere which possess a high con- 
tent of type-specific antibodies. 
DISCUSSION. 
The experiments recorded in the present  communication demon- 
strate  that  a considerable  degree  of  active  immunity against  Type I 
and  Type  II  pneumococci may be stimulated  in rabbits  by repeated 
injections  of R pneumococd.  This form of  resistance,  elicited  by R 
organisms which are  devoid  of  type  specificity,  is  effective  in  the  absence 
of demonstrable type-specific  agglutinins,  precipitins,  and antibodies 
passively protective for mice.  In a preceding  paper (1) it was reported 
that rabbits similarly treated are resistant to virulent Type III organ- 
isms; the present results with Types I and II establish the fact that im- 
munity induced in rabbits  by  R  strains  is  sufficiently broad  to  be 
effective against infection  with each of the three specific types of pneu- 
mococcus.  The Type III infections as previously pointed out, were 
characterized by a  bacteremia which ran a  polonged course during 
which the number of circulating bacteria varied from time to time but 
eventually disappeared.  The Types I  and II infections encountered 
in the present experiments behave similarly.  These facts are sugges- 
tive that in this form of immunity the mode of recovery from infection 
involves the same mechanism, or different mechanisms acting in a 
similar manner, against each type of pneumococcus.  Furthermore, 
these results strongly imply that  resistance under these conditions is 
dependent either upon other factors than those concerned in type- 
specific immunity, or upon the same factors operative in a  different 
manner. 
Although the majority of previous investigators  have found that 
active immunity  against  pneumococcus  infection  is type-specific,  the ex- 802  IMMUNITY  TO  PNEU~OCOCCUS  INFECTION 
perimental conditions, either as to the species of animal or the method 
of immunization employed, have differed from those reported in this 
paper.  Cecil and Blake  (6)  observed that in monkeys vaccination 
with living cultures of Type I conferred a certain amount of cross-im- 
munity, the degree of effectiveness being subject to variation.  The 
immunizing dose in their experiments consisted of one  subcutaneous 
injection of either 0.001 cc. of virulent or 1 to 2 cc. of avirulent organ- 
isms.  Wright  (7)  found that  one  preliminary intravenous injection 
of S pneumococci produced active immunity in rabbits effective only 
against homologous organisms.  Barach (8) employing mice gave one 
intraperitoneal  injection of  S  organisms and  obtained  strict  type- 
specific immunity. 
In the experiments here reported the active resistance which was 
stimulated  by  immunization with  R  pneumococci and  which  was 
found to be effective against all the fixed types, was obtained  by a 
more prolonged series of injections.  The process of immunization 
comprised 18  intravenous injections carried  out over a  period of 6 
weeks according to  the method described by  Cole and Moore  (2). 
Although the degree of immunization necessary to incite non-type- 
specific immunity has not been determined, it has been found that one 
injection of from 5 cc. to 25 cc. of R culture is insufficient. 
The purpose of these  experiments has  been an attempt to under- 
stand the factors underlying the resistance.  Since this form of cross- 
immunity can  be  induced by pneumococci devoid of type-specific 
properties, it seems highly probable that a mechanism of a  different 
order  from  that  involved in  type-specific resistance  is  implicated. 
Work is in progress at the present to define more dearly the points 
of similarity  and  difference between  these  two  forms of acquired 
resistance. 
Having determined the presence of active immunity in rabbits pre- 
viously treated with R  cells, consideration has been given to passive 
immunity.  Since  one  of  the  chief  characteristics  of  type-specific 
immunity is the passive protection afforded animals of any species by 
an immune serum of the homologous type a  study of the possibility 
of passively transferring this non-specific resistance has been carried 
out.  It was found that whole blood or serum of R immunized rabbits 
protected normal rabbits against infection with virulent Type I  and WILLIA~  S. TILLETT  803 
Type III pneumococci.*  As a rule, blood in 15 to 20 cc. amounts was 
found to afford a more solid resistance against a  given infecting dose 
than the equivalent amount of serum. 
Under the experimental conditions described the most striking re- 
suits have been obtained when an interval of time elapsed between the 
transfusion and the injection of organisms.  The exact significance of 
these relations has not as yet been sufficiently studied to justify final 
conclusions.  However, it can be stated at the present time, that the 
immunity elicited by repeated injections of R pneumococci in rabbits 
can be passively transferred by the circulating blood to normal rabbits. 
This is evidence that there is present in the circulation of resistant 
rabbits either protective substances in an active state or something 
which stimulates the mechanism  of resistance in the transfused animal. 
Attempts to confer passive protection on mice under similar condi- 
tions have been uniformly negative.  This failure is in sharp contrast 
to the positive results always obtained in mice with type-specific sera, 
and is further evidence of a  difference in the mechanism involved in 
each instance. 
SUMMARY. 
1.  Rabbits,  vaccinated by repeated intravenous injections of sus- 
pensions of heat-killed R  pneumococci, acquire a  marked degree of 
active immunity to infection with the virulent S forms of Pneumococ- 
cus Types I  and II.  Previously (1)  it was  shown that the immuni- 
zation of rabbits with R  cells induces active resistance to  Type III 
infection.  This immunity is effective when the infecting organisms 
are injected either intravenously, intraperitoneally, or intradermally. 
2.  Whole citrated  blood or  serum of rabbits  immunized with  R 
pneumococci, under the experimental conditions described, is capable 
of passively protecting normal rabbits against Type I and Type III in- 
fection.  Whole blood appears to be more effective than an equivalent 
amount of serum. 
3.  Passive protection of mice by the use of whole blood or serum of 
* Resistance to Type II was not tested by reason of the fact that an R  strain 
originally derived from Type II S culture was used for immlmization.  It seemed 
desirable to minimize  the possible participation of type-specific substances. 804  IMMUNITY  TO  PNEUMOCOCCUS  INFECTION 
the immune rabbits has been entirely ineffectual.  This is in striking 
contrast to the results obtained with type-specific immune serum. 
4.  This  form of  acquired  resistance  to  pneumococcus  infection, 
elicited by R organisms which are devoid of type specificity, and exem- 
plified in animals whose sera possess no  demonstrable  type-specific 
antibodies,  has  many 
underlying  mechanism 
immunity. 
characteristics  strongly  suggesting  that  the 
differs  from that  concerned in type-specific 
CONCLUSION. 
A  broad immunity against infection with virulent  S pneumococci 
(Types I, II, and III) can be induced in rabbits by vaccination with the 
degraded R  strains of pneumococcus.  This form of active resistance 
is  effective in the  absence of demonstrable  type-specific antibodies, 
and may be passively transferred to normal rabbits by the blood of the 
immunized animal. 
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